Total Visits

Views
Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study86

Total Visits Per Month

April 2021May 2021June 2021July 2021August 2021September 2021October 2021
Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study4000400

File Downloads

Views
12888_2018_1826_MOESM1_ESM.docx79
12888_2018_Article_1826.pdf25

Top country views

Views
United States57
Germany9
China6
Russia3
France2
United Kingdom2
Lebanon2
Albania1
Ireland1
Netherlands1

Top cities views

Views
Ashburn39
Oakland5
Fairfield4
Moscow3
Beirut2
Boydton2
Hangzhou1
Hefei1
Hjellestad1
Istanbul1